Skip to content

Microdosing: all studies

Page 45 of 56: studies 441 to 450 of 555, newest first. Back to the microdosing overview

Research

B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations

Archives of Clinical Neuropsychology September 12, 2024 James Perry, Cara C. Young, Julie Williams 1 citation

Abstract Objectives The first line for symptom management of attention deficit hyperactivity disorder (ADHD) is a class of medications that act on dopamine and noradrenaline receptors, which leads to symptom reduction at the cost of significant side effects. These side effects have led to community searching for alternative methods that manage ADHD symptoms in adults that lead to less side...

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?

Ask the expert – Psychedelic substances September 1, 2024 A. E. Ayad

One of the main causes of misery and incapacity is chronic pain, which is frequently linked to psychological issues. Psychedelic substances are drugs that can exert a psychological effect on patients. Psychedelic drugs like lysergic acid diethylamide (LSD) and psilocybin, exert their action mainly via activation of the serotonin-2A (5-HT2A).1 In a trial to understand the actual mode of action...

Los mecanismos y efectos de los psicodélicos

August 30, 2024 Mercedes Guaia Memita Guaia

Los psicodélicos generalmente provocan un cambio profundo en la conciencia, frecuentemente con disolución del ego, experiencias místicas y una percepción sensorial enriquecida, aunque son médicamente seguros para la mayoría de las personas. La taquifilaxia ocurre tras la administración repetida de psicodélicos, lo que impide la dependencia biológica. El MDMA puede tener cierto potencial de...

The Mechanisms and Effects of Psychedelics

August 30, 2024

Psychedelics generally elicit a profound change in consciousness, often with ego dissolution, mystical experiences, and enriched sensory perception, but are medically safe for most. Tachyphylaxis occurs after repeated psychedelic administration, preventing biological dependence. MDMA may have some abuse potential and less tachyphylaxis compared to LSD/psilocybin. Psychedelics have 5-HT2B...

Drugie życie psychodelików

Kosmos August 8, 2024 Krystyna Gołembiowska, K. Kamińska

Psychedelics known for mankind from millennia are class of compounds that alter consciousness, affect perception and produce hallucinations. Classic psychedelics such as psilocybin, mescaline, dimethyltryptamine (DMT) and lysergic acid diethylamide (LSD) have pharmacodynamic serotonergic effects. They are known to exert profound effects on neuroplasticity i.e. alteration of neuronal structure...

The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world.

International Journal of Drug Policy August 1, 2024 Stephanie Lake, Philippe Lucas 31 citations

Despite advancements in policies governing psychedelic substances globally, our understanding of real-world psychedelic use and its variations across international jurisdictions remains limited. We implemented the Global Psychedelic Survey (GPS) to capture information about psychedelic consumer characteristics, access, and usage patterns around the world. The GPS was administered online in...

DOI: 10.1016/j.drugpo.2024.104507 (opens in new tab) Full text (opens in new tab) Comparative analysis Psychedelics research International drug survey Substance use patterns +2

Expanding Mindscapes: A Global History of Psychedelics. By ErikaDyck, ChrisElcock (Eds.), Cambridge, MA: The MIT Press. 2023. ISBN: 9780262546935

Addiction July 29, 2024 Peder Clark

When the Saskatchewan-based British psychiatrist Humphry Osmond first wrote to his fellow British émigré, novelist Aldous Huxley, he could have had little idea of how the ripples of their private correspondence of the early 1950s would reverberate across the world and into the future. But here we are in 2024, and the term that Osmond coined—‘psychedelic’—is quite literally everywhere, from...

[Psilocybin fungi microdose treatment in major depressive disorder: a case report].

Vertex Revista Argentina de Psiquiatría July 10, 2024 Mariana Zarankin, María S Pellegrini, Francisco Zenteno 2 citations

Major depression disorder is an entity with high prevalence and worldwide impact. Current treatments present a non-response rate of 15-30%, and certain adverse effects are seen like apathy syndrome and lack of emotional response. It is stated that the treatment with psilocybin fungi allows the possibility of dose reduction and suspension of classic psychotropic drugs and entails changes on an...

Hallucinogens, dissociative drugs, and empathogens

Oxford Handbook of Addiction Medicine June 1, 2024

Abstract Chapter 16 of Addiction Medicine covers hallucinogens, dissociative drugs, and empathogens. Hallucinogens, also termed psychedelics, are a large and diverse group of substances, some of which occur in fungi and plants and some which are chemically synthesized. Some have psychostimulant properties as well. They include psilocybin, mescaline, dimethyltryptamine (DMT), ayahuasca, lysergic...

Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders

May 2, 2024 Hanna Brancaccio

Introduction: Substance use disorder (SUD) and alcohol use disorder (AUD) are major public health crises, affecting millions of Americans. Current treatment options include behavioral therapies and medications. In this review, we explored psilocybin’s efficacy in treating SUD and AUD. Methods: Key terms were used to search databases to identify articles that addressed psilocybin in the...